Poolbeg Pharma (POLB) Ord Shares
No change
- Add to watchlist
- Create an alert
- This stock can be held in a
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
2.85p
2.89p
14.30p
£14.25 million
2.85p
2.86p
2.40p
n/a
0.05p (1.72%) Previous:
0.05p
50,281
n/a
75,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | n/a | n/a |
| Profit before tax (£m) | (4.50) | (4.78) |
| Adjusted EPS (p): | (0.79) | (0.94) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Poolbeg shares slide as Hookipa terminates takeover talks
21 February 2025 10:38
-
Poolbeg Pharma says Gilead in favour of its combination with Hookipa
10 January 2025 16:06
-
Poolbeg Pharma granted new US patent
20 November 2024 13:56
-
Conference Participation in March & April 2025
27 March 2025 07:00
-
POLB 001 Patent Granted in Korea
20 March 2025 07:00
-
Form 8.5 (EPT/NON-RI)
25 February 2025 08:50
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.